Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-03

Clinical Trial Update: Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy of valbenazine for adults with trichotillomania (hair-pulling disorder) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INGREZZA (valbenazine)

Snippet

Sponsor: Yale University | Conditions: Trichotillomania (Hair-Pulling Disorder) | Phase 2 | Status: RECRUITING